GHP Q2 2021

40 GHP / Q2 2021 , Feb21350 With a history of excellence in the life sciences industries, MakroCare UKwas recently awarded the accolade of Best Biopharma &Medical Device Development & Commercialization Specialists 2021. We find out more about the firmand its expertise in strategic development and global commercialisation for the pharmaceutical, biotechnology, andmedical device sectors. MakroCare UK MakroCare UK is an expert strategic development and global commercialisation partner for the pharmaceutical, biotechnology and medical device industries. The firm’s experience, programmes and processes bring a new dimension to development strategy, regulatory/risk planning and management, clinical research, medical/scientific support and emerging region expansion. With five main divisions of Consulting, CRO, DDi (Informatics), SMO, and Commercialization, MakroCare offers services in project management, regulatory affairs, risk management, site selection, patient recruitment, trial management (P II/III and late phase), clinical monitoring, biometrics, safety/pv, informatics (eClinical products, solutions), medical affairs, bpo and call centre services. Serving the life sciences industry since 1996, MakroCare is well positioned to meet the demands of the expanding product portfolio needs of its life sciences clients worldwide and also understand the demands of an increasingly competitive market. Mr. Mahesh Malneedi co-founded MakroCareClinical Research Limited 25 years ago and still serves as its President today. Holding an MS and an MBA from NJIT, New Jersey, Mr. Malneedi was instrumental in the start-up and growth of MakroCare, as Best Biopharma &Medical Device Development & Commercialization Specialists 2021 one of the fastest growing CROs. His many years of business experience is a valuable asset to the company, and he cut his teeth at various wall street firms such as JP Morgan, Solomon Smith Barney and Citibank. To date the company has supplied more than 60 countries with its regulatory and clinical services; provided offerings to more than 700 FTEs and consultants; supports more than 4,000 products; and served more than 1,400 customers. As a United States headquartered company, MakroCare also has operations in the United Kingdom, Europe, and Asia. Its UK office joins the existing presence in Germany and Switzerland, meaning that the firm can now offer even more European support to its global customers. Recently, MakroCare UK was awarded with the prestigious title of Best Biopharma & Medical Device Development & Commercialization Specialists 2021, honouring the company’s best-in-class services and development initiatives within the life sciences industry. This award is added to its roster of previous accolades, such as its inclusion in Inc 5000 list of America’s Fastest Growing Private Companies and the Deloitte Technology Fast 500. MakroCare’s success is the result of more than 20 years of industry experience and knowledge, providing clients with a broad range of contract and consulting services to the worldwide biopharmaceutical and medical device industries. Company: MakroCare UK Web Address: www.makrocare.com